Search
Skip to Search Results- 23CIHR
- 5Coe, Helen - Project Coordinator, Grant Assist Program (Health Sciences)
- 4McPhalen, Cathy - PhD, thINK Editing
- 4Simala-Grant, Joanne - Director, Grant Assist Program (Health Sciences)
- 4Simala-Grant, Joanne - Director, Health Funding Research Initiatives
- 2Coe, Helen - Project Coordinator, Grant Assist Program
- 48Toolkit for Grant Success
- 44Toolkit for Grant Success/Agency Resources (Toolkit for Grant Success)
- 6Graduate and Postdoctoral Studies (GPS), Faculty of
- 6Graduate and Postdoctoral Studies (GPS), Faculty of/Theses and Dissertations
- 4Toolkit for Grant Success/Educational Materials (Toolkit for Grant Success)
- 2Communications and Technology Graduate Program
-
Advancing Behavioural Supports Alberta (BSA) A Secondary Data Analysis of the November 21st, 2012 Challenging/Responsive Behaviours Symposium: Developing An Alberta Action Plan
Download2013-12-02
Germani, Tamara, Lee Jennifer, Friesen, Steven, Bremault-Phillips, Suzette
Purpose of the Report The purpose of this report is to communicate summary findings of relevant themes and recommendations identified through a secondary analysis of the November 21, 2012 Challenging/Responsive Behaviours Symposium. The aim is to inform the development of a provincial action plan...
-
Fall 2020
Cryptographic (crypto) Application Programming Interfaces (APIs) play an important role in application security; unfortunately crypto APIs are difficult to use, which may lead to security vulnerabilities. Prior work have looked at detecting and fixing crypto APIs misuses at development time and...
-
2015-01-29
Dr. Jane Aubin (Chief Scientific Officer & Vice-President, Research, Knowledge Translation & Ethics Portfolio, CIHR) gave a broad overview on changes at CIHR. There was significant time for a question and answer period.<br></br> Please select \"download\" to download the PowerPoint and...
-
Fall 2014
Randomized controlled trials for a rare disease face methodological difficulties in evaluating treatment effects due to characteristics of rare diseases such as a small patient population to recruit from, lack of knowledge about the disease itself (i.e., lack of clinically validated endpoints),...